Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient

Primary or degenerative mitral regurgitation (MR) occurs frequently. Even though surgery continues to be the standard treatment at present, it remains risky for one group of patients, which makes edge-to-edge mitral valve repair (MV-TEER) a viable alternative. 

Centera Valvula expandible

We are well aware that moderate to severe MR is associated with worse prognosis. However, post procedural mean gradient analysis (ppMG) has not been carried out exhaustively and the available data on primary MR remains limited. 

The study looked at 371 patients undergoing edge-to-edge repair with MitraClip, from the GISE and GIOTO registries. At the end of the procedure, 187 patients presented <3 mmHg ppMG, 77 >3/=4 mmHg ppMG and 107 >4 mmHg ppMG.

Primary end point was all cause death or hospitalization driven by cardiac failure within 12 months. 

There were no significant differences between the three groups of patients. Mean age was 85, and 51% were women. Also, 71.3% were hypertensive, 16.5% diabetic, 21.2% had chronic obstructive pulmonary disease (COPD), 40.4% presented atrial fibrillation, 22% had CAD and 45% had been hospitalized for cardiac failure. Also, 10% had a history of MI, 17% had had prior heart surgery and 70% were in functional class III-IV. STS mortality rate was 3.7%.

Leia também: EASTBOURNE Registry: Use of Sirolimus-Coated Balloons in Coronary Artery Disease.

Mean ejection fraction was 57%, and 4.6% had ≤35% ejection fraction. Echocardiographic values showed LV diastolic diameter 53, LV systolic diameter 35, end diastolic volume 110 ml and pulmonary artery systolic pressure 45 mmHg.

36% of patients received just one clip, while 59% received two. No relationship was found between the number of clips and higher ppMG. Patients with ppMG >3/=4 presented more residual MR >2+ by the end of the procedure vs the other two groups. 

After one year, no differences were found between the three groups in terms of mortality or hospitalization for cardiac failure. 

Leia também: Left Atrial Appendage Closure: As Effective in Men and Women?

At multivariable analysis, neither ppMG >4mmHg not ≥5 mmHg were predictors of bad evolution, though so the case for ppMG ≥4 mmHg together with residual MR ≥2+ (hazard ratio: 1.98; 95% confidence interval: [1.10–3.58]).

Conclusion

In this cohort of patients with degenerative MR treated with edge-to-edge repair, no link was found between post procedural mean gradient and one-year prognosis. However, a considerable number of patients did experience an increase in post procedural gradient and residual MR, and the combination of both factors seems to be a solid predictor of adverse events. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Postprocedural trans‐mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge‐to‐edge repair.

Reference: Francesco De Felice, et al . Catheter Cardiovasc Interv. 2023;102:310–317.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...